Document is current
Any future updates will be listed below
-
Authors
De Greef, Julien
Nguyen, Khoi Nguyen
Van Hul, Matthias
Puel, Anthony
Yombi, Jean Cyr
Vandercam, Bernard
Vincent, Anne
Elens, Laure
Belkhir, Leïla
Haufroid, Vincent
Cani, Patrice D.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04805944 at ClinicalTrials.govDocuments that mention this clinical trial
Associations between weight gain, integrase inhibitors antiretroviral agents, and gut microbiome in people living with HIV: a cross-sectional study
https://doi.org/10.1038/s41598-025-06500-0
-
Funding
Funding for this research was provided by:
Fonds Spéciaux de Recherche
Fonds de Recherche Clinique
Walloon excellence in life sciences and biotechnology (WELBIO-CR-2022A-02)
Fonds De La Recherche Scientifique - FNRS (FNRS-CDR J.0085.21, program no. 40007505)
- License Information
-
More Information
Article History
Received: 20 November 2024
Accepted: 9 June 2025
First Online: 2 July 2025
Declarations
:
: The study received approval by the local Ethical committee (Comité d’éthique Hospitalo-facultaire from Cliniques universitaires Saint-Luc-UCLouvain; 2020/30NOV/593) and regulatory authorities (Eudra-CT Number 2020-001103-17). All participants gave written informed consent before taking part in the study. All methods were performed in accordance with the relevant guidelines and regulations.
: The trial is registered with ClinicalTrials.gov, NCT04805944 (registration date 2021–03-16).
: PDC is inventor on patent applications dealing with the use of specific bacteria and components in the treatment of different diseases. PDC was co-founder of The Akkermansia Company SA and Enterosys. The other authors declare no competing interests.
